Cytomegalovirus management after allogeneic hematopoietic stem cell transplantation: A mini-review

Cytomegalovirus management after allogeneic hematopoietic stem cell transplantation: A mini-review

Because of the high incidence of cytomegalovirus (CMV) seropositivity in the population, CMV infection is a common and severe complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in Taiwan. Here we propose a CMV management strategy for patients undergoing allo-HSCT from the...

Full description

Bibliographic Details
Main Authors:	Chieh-Lin Jerry Teng, Po-Nan Wang, Yee-Chun Chen, Bor-Sheng Ko
Format:	Article
Language:	English
Published:	Elsevier 2021-06-01
Series:	Journal of Microbiology, Immunology and Infection
Subjects:	Allogeneic hematopoietic stem cell transplantation Cytomegalovirus Prophylaxis Preemptive Ganciclovir
Online Access:	http://www.sciencedirect.com/science/article/pii/S1684118221000141

Similar Items

Mutations in the cytomegalovirus UL97 gene associated with ganciclovir resistance in recipients of allogeneic hematopoietic stem cell transplants
by: Demin M.V., et al.
Published: (2019-12-01)

Valganciclovir for cytomegalovirus preemptive therapy in patients following allogeneic hematopoietic stem cell transplantation
by: LU Xuan, et al.
Published: (2020-09-01)

The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir
by: Regina Schröeder, et al.

Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy
by: Restelli U, et al.
Published: (2019-05-01)

Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high‐risk hematopoietic cell transplant recipients
by: Léna Royston, et al.
Published: (2021-09-01)

Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
by: Xuan Li, et al.
Published: (2012-08-01)

Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort Study
by: Léna Royston, et al.
Published: (2021-04-01)

Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience
by: Massimo Martino, et al.
Published: (2021-09-01)

CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRUS INFECTION IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS
by: O. M. Tsiroulnikova, et al.
Published: (2016-04-01)

The association of conditioning regimen with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
by: Masoud Mardani, et al.
Published: (2020-12-01)

Relations exposition-effets et pharmacogénétique du ganciclovir chez le patient transplanté
by: Billat, Pierre-André
Published: (2015)

Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein–Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant
by: Ndeye Soukeyna Diop, et al.
Published: (2021-06-01)

Profilaxia universal versus terapia preemptiva com ganciclovir endovenoso no manejo da citomegalovirose em pacientes submetidos a transplante pulmonar
by: Sánchez, Leticia Beatriz
Published: (2017)

Profilaxia universal versus terapia preemptiva com ganciclovir endovenoso no manejo da citomegalovirose em pacientes submetidos a transplante pulmonar
by: Sánchez, Leticia Beatriz
Published: (2017)

Profilaxia universal versus terapia preemptiva com ganciclovir endovenoso no manejo da citomegalovirose em pacientes submetidos a transplante pulmonar
by: Sánchez, Leticia Beatriz
Published: (2017)

Risk factors of CMV replication after allogeneic hematopoietic stem cell transplantation in children and adolescents
by: S. N. Shiriaev, et al.
Published: (2014-09-01)

Risk factors of CMV replication after allogeneic hematopoietic stem cell transplantation in children and adolescents
by: S. N. Shiriaev, et al.
Published: (2014-09-01)

Conditioning Regimens in Allogeneic Hematopoietic Stem Cell Transplantation
by: Betul Tavil
Published: (2014-02-01)

Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient
by: Susanne Jung, et al.
Published: (2019-05-01)

Trip to immunity: resistant cytomegalovirus infection in a lung transplant recipient
by: Nikolaus Kneidinger, et al.
Published: (2014-11-01)

Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
by: Lauren Stern, et al.
Published: (2019-05-01)

Maintenance Treatment With Low-Dose Decitabine After Allogeneic Hematopoietic Cell Transplantation in Patients With Adult Acute Lymphoblastic Leukemia
by: Jia Liu, et al.
Published: (2021-08-01)

Cytomegalovirus induced pseudotumor of the colon in a renal transplanted patient
by: Syed Mudassir Laeeq, et al.
Published: (2017-04-01)

The risk factors for cytomegalovirus reactivation following stem cell transplantation
by: Bahareh Valadkhani, et al.
Published: (2016-01-01)

Lung transplantation for late-onset non-infectious chronic pulmonary complications of allogenic hematopoietic stem cell transplant
by: Peter Riddell, et al.
Published: (2021-04-01)

Association of Patient-Reported Physical Activity on Allogeneic Hematopoietic Cell Transplant Outcomes
by: Reena V. Jayani, et al.
Published: (2021-03-01)

Spontaneous fertility in a male thalassemic patient after allogeneic hematopoietic cell transplantation
by: Nicoletta Iacovidou, et al.
Published: (2017-11-01)

Hepatitis E and Allogeneic Hematopoietic Stem Cell Transplantation: A French Nationwide SFGM-TC Retrospective Study
by: Aliénor Xhaard, et al.
Published: (2019-07-01)

Bilateral cytomegalovirus retinitis in a healthy infant
by: Seyedeh Maryam Hosseini, et al.
Published: (2017-03-01)

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies
by: Mohammad Faizan Zahid, et al.
Published: (2014-12-01)

Quimerismo molecular en el trasplante alogénico de células hematopoyéticas: Resultados preliminares Molecular chimerism in the allogeneic transplantation of hematopoietic cells: Preliminary results
Published: (2005-12-01)

A Review of Allogeneic Hematopoietic Stem Cell Transplantation in Metastatic Breast Cancer
by: Nuri Karadurmus, et al.
Published: (2018-04-01)

Physiological problems in patients undergoing autologous and allogeneic hematopoietic stem cell transplantation
by: Sevgisun Kapucu, et al.
Published: (2014-01-01)

The benefit of exercise in patients who undergo allogeneic hematopoietic stem cell transplantation
by: Shinichiro Morishita, et al.
Published: (2019-01-01)

LYMPHOID NEOPLASMS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION. THE CASE OF SECONDARY HODGKIN’S LYMPHOMA, DIFFERENTIAL DIAGNOSIS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
by: Yu. V. Skvortsova, et al.
Published: (2017-06-01)

Pneumothorax in an early phase after allogeneic hematopoietic stem cell transplantation
by: Yasuhiro Ebihara, et al.
Published: (2013-06-01)

Aetiology of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation
by: Vasilieva V.A., et al.
Published: (2018-08-01)

Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation
by: Wen-Rong Huang, et al.
Published: (2018-01-01)

A Comparison of Allogeneic and Autologous Hematopoietic Stem Cell Transplantation for Acute Myeloblastic Leukemia
by: Ardeshir Ghavamzadeh, et al.
Published: (2009-03-01)

A Comparison of Allogeneic and Autologous Hematopoietic Stem Cell Transplantation for Acute Myeloblastic Leukemia
by: Farnaz Khatami, et al.
Published: (2009-01-01)